HYPNOMIDATE 2 mg/ml, solution for injection 5 ampoules of 10 ml
Active ingredients: Etomidate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HYPNOMIDATE 2 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- PIRAMAL CRITICAL CARE (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Jul 1987
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63444171CIP75606919CIP133400956069194Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTOMIDATEsolution | 2 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.